Anamnesis 42-year-old woman.
A professional violonchelist, with a personal history of hysterectomy plus double adnexectomy, endometriosis, in 2008 diagnosed with multiple sclerosis, parccioxente recurrent (EMRR) in 1997, on treatment with beta 1a interferon
Do not consume herbal products.
She came to the emergency department because of a 2-day history of severe abdominal pain and vomiting.
The patient reported feeling of gastric heaviness, nausea and asthenia in the previous 15 days.
She did not report toxic consumption.
One patient had been previously treated with methylpredni 5 g of 1 g of intravenous broth with interferon 1b doses from 22 mg to 44 mg, after presenting a clinical picture compatible with multiple-month intravenous beta-cell broth.
Acquired mental illness, mental illness, mental illness, mental illness, mental illness, mental illness, mental illness, mental illness, etc.
Cardiopulmonary arrest normal.
The abdomen was painful to the apex of the right upper quadrant.
Palpation of painful hepatic border, 2 cm below the costal margin.
Peripheral peace preserved.
No edema or signs of chronic venous insufficiency.
Neurological manifestations: mild tactile hypoesthesia in the left limbs and exalted osteotendinous reflexes, cutaneous-plantar reflex of the left extensor.
No other focus (EDSS 1.5).
▁Complementary tests • Blood analysis: elevated total serum bilirubin (GOT/GPT 625 IU/l/1.055 IU/l, GGT 471 IU/l, LDH 628 IU/l).
The hemogram showed 11,300 leukocytes with 70% neutrophils, platelets 450,000.
VSG 53 mm.
The▁ferric profile showed no alterations or other relevant findings.
• Serology: HAV, HBV and HCV negative.
CMV and EBV negative.
• Immunological study: ANA, SMA, anti-LKM1, pANCA, anti-LC1 and AMA negative.
• Genetic study: negative for mutations in the HFE gene of hereditary hemochromatosis.
• Abdominal ultrasound: enlarged liver, patchy hyperechogenicity.
No free fluid in the abdominal cavity.
• Hepatic biopsy: necrosis and portal and periportal inflammation, with interface hepatitis, with minimal fibrosis.
Not conclusive.
Diagnosis Acute hepatitis grade 4 secondary to hepatotoxicity caused by interferon beta.
Treatment Withdrawal of prior treatment.
Prednisone 60 mg daily intravenously over 5 days followed by orally reducing the dose slowly by about 6 weeks until withdrawal.
The patients evolution is admitted to the Gastroenterology Service.
All the treatment he was taking up to that moment was withdrawn and high-dose corticotherapy (1 mg/kg/day) was started intravenously.
The patient has a progressive clinical improvement.
A week later control analysis showed marked decrease in transaminase levels (GOT/GPT 225 IU/l/398 IU/l, GGT 240 IU/l) and normalization at 15 days.
One month later, the patient remains asymptomatic, with no new complications, so it is decided to resume the modulating treatment of the disease for multiple sclerosis with glatiramer acetate.
